Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertise
CDMO-sponsor relationships are moving away from simple outsourcing toward deeper strategic collaboration. Companies now look for partners who share risk, understand regulatory requirements, and provide technical insight.
Increasing compliance demands and geopolitical volatility are reshaping manufacturing, prompting sponsors to seek CDMOs that can anticipate and mitigate potential hurdles before they arise.
Jeff Mocny, vice president for Scientific Leadership at Rose BioSolutions, said the firm aims to challenge customer assumptions and protect programs early, rather than merely executing tasks.
This writeup was produced by pharmadog from original reporting by BioSpace.
Original headline: “Successful CDMO partnerships hinge on honest—and sometimes critical—support”
read at BioSpace ↗
comments(0)
5-min edit window · permanent after that